Pharming Drug Patent Portfolio
Pharming owns 1 orange book drug protected by 1 US patent Given below is the list of Pharming's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8653092 | Tetrahydro-pyrido-pyrimidine derivatives | 19 Feb, 2032 | Active |
Latest Legal Activities on Pharming's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Pharming.
| Activity | Date | Patent Number |
|---|---|---|
| ||
| Second letter to regulating agency to determine regulatory review period | 15 May, 2024 | US8653092 |
| Letter from FDA or Dept of Agriculture re PTE application | 07 Feb, 2024 | US8653092 |
| Initial letter Re: PTE Application to regulating agency | 01 Dec, 2023 | US8653092 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 27 Oct, 2023 | US8653092 |
| Requirement for information sent under 37 CFR 1.750 | 01 Sep, 2023 | US8653092 |
|
Electronic Review
Critical
| 29 May, 2023 | US8653092 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 23 May, 2023 | US8653092 |
|
Email Notification
Critical
| 23 May, 2023 | US8653092 |
| Patent Term Extension Application under 35 USC 156 Filed | 22 May, 2023 | US8653092 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Aug, 2021 | US8653092 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 30 Jan, 2020 | US8653092 |
|
Email Notification
Critical
| 30 Jan, 2020 | US8653092 |
| Sequence Moved to Public Database | 19 Feb, 2014 | US8653092 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 18 Feb, 2014 | US8653092 |
|
Recordation of Patent Grant Mailed
Critical
| 18 Feb, 2014 | US8653092 |
Pharming's Family Patents
Pharming Drug List
Given below is the complete list of Pharming's drugs and the patents protecting them.
1. Joenja
Joenja is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8653092 | Tetrahydro-pyrido-pyrimidine derivatives |
19 Feb, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Joenja's drug page